🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 3 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/01/2022 49,31 53,32 47,29 52,79 +3,84% 12,22% 1.130.500
21/01/2022 51,62 53,49 50,82 50,84 -3,18% 5,17% 766.400
20/01/2022 54,30 55,59 52,35 52,51 -2,38% 5,97% 884.300
19/01/2022 55,64 56,00 53,64 53,79 -0,63% 4,24% 596.500
18/01/2022 56,39 56,47 54,02 54,13 -6,37% 4,34% 587.800
14/01/2022 56,85 58,96 55,28 57,81 +0,40% 6,48% 593.900
13/01/2022 58,39 58,94 57,33 57,58 -1,10% 2,76% 510.500
12/01/2022 60,54 61,25 58,16 58,22 -3,32% 5,10% 597.600
11/01/2022 59,62 60,69 58,12 60,22 +1,16% 4,31% 561.000
10/01/2022 58,22 59,68 57,05 59,53 +0,98% 4,52% 539.800
07/01/2022 60,48 62,25 58,79 58,95 -3,20% 5,72% 560.800
06/01/2022 60,28 62,09 58,03 60,90 +1,20% 6,74% 608.500
05/01/2022 64,35 65,64 59,95 60,18 -7,47% 8,85% 1.068.700
04/01/2022 68,61 69,83 64,25 65,04 -7,05% 8,14% 867.700
03/01/2022 66,25 70,09 63,72 69,97 +5,54% 9,62% 674.400
31/12/2021 67,05 68,94 65,51 66,30 -1,56% 5,12% 476.400
30/12/2021 67,50 69,23 66,83 67,35 +0,87% 3,56% 463.000
29/12/2021 66,10 67,00 65,12 66,77 +1,07% 2,84% 340.200
28/12/2021 66,50 68,50 65,94 66,06 -0,36% 3,85% 349.600
27/12/2021 70,01 70,24 66,14 66,30 -5,62% 5,86% 619.900
23/12/2021 70,00 71,00 69,07 70,25 +0,62% 2,76% 515.900
22/12/2021 70,00 70,15 68,26 69,82 -0,40% 2,70% 432.600
21/12/2021 71,00 71,15 69,29 70,10 -0,61% 2,62% 424.800
20/12/2021 68,91 71,10 67,83 70,53 +1,25% 4,75% 714.900
17/12/2021 65,01 70,14 65,01 69,66 +6,91% 7,89% 1.648.100
16/12/2021 70,66 70,70 65,01 65,16 -7,38% 8,05% 1.062.300
15/12/2021 67,98 70,39 65,64 70,35 +2,78% 6,99% 749.900
14/12/2021 69,54 71,43 67,41 68,45 -4,24% 5,78% 610.900
13/12/2021 70,29 72,83 69,50 71,48 +2,01% 4,74% 596.100
10/12/2021 70,59 73,03 69,28 70,07 -1,07% 5,31% 515.000